￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is it necessary to insist on taking the full course of Epclusa medication and analysis of the risks of discontinuation of medication?

2026-02-01 22:25:32

Check Details
How long should you take Sunitinib (Sutent) before you can stop taking it and what are the suggestions for observing the course of treatment?

2026-02-01 22:25:32

Check Details
The main types of diseases and clinical applications treated by tazetostat (Davico)

2026-02-01 22:25:32

Check Details
Ceritinib/Ceritinib (Zanda) belongs to which generation of drugs and analysis of its clinical significance

2026-02-01 22:25:32

Check Details
Besotivan (Viliru) is not suitable for users and its contraindications

2026-02-01 22:25:32

Check Details
Dabrafenib (Tefila) daily dosage and safe dosage range instructions

2026-02-01 22:25:32

Check Details
The half-life of axitinib (Inlida) and its impact on the dosing interval

2026-02-01 22:25:32

Check Details
Observation on the efficacy and long-term use of trametinib (Megenin) in patients with lung cancer

2026-02-01 22:25:32

Check Details
Is avatrombopag (Sucoxin) a hormonal drug and its differences

2026-02-01 22:25:32

Check Details
Safety and risk of adverse reactions of long-term use of giritinib (segatan)

2026-02-01 22:25:32

Check Details
Analysis of the efficacy and risk of worsening of lung cancer treated with Canafenib/Encofenib (Betavit)

2026-02-01 22:25:32

Check Details
Economic analysis of one-month cost and long-term medication of Imatinib

2026-02-01 22:25:32

Check Details
Category
相关知识